{"modelId":"v24_source_feature_integration","admissibilityStatus":"blocked_sample_not_clinical_evidence","clinicalUseStatus":"prohibited","canClaimDiseaseDetection":false,"eligibleForRetrospectiveEvidence":false,"blockingGateCount":3,"blockingGates":["template_fingerprint","source_manifest","schema_and_minimums"],"cohortDiversity":{"uniqueSites":2,"positiveRows":2,"negativeRows":2},"phiValueScreen":{"checkedRows":4,"phiLikeValueCount":0},"nextActions":["Provide a real DUA/IRB-appropriate deidentified cohort plus source manifest before Pass102/104 evidence use.","Reject any cohort with template fingerprints, PHI-like values, duplicate patient-gene candidates, missing governance metadata, or Pass101 minimum failures.","Only after Pass105 and Pass101 pass should the frozen v24 score join and locked retrospective acceptance gates be run.","Keep clinical disease-detection, diagnosis, treatment-support, and patient-specific interpretation claims prohibited until retrospective and prospective gates pass."],"dryRunPath":"/repo/artifacts/downloads/training/pass105_cohort_admissibility_dry_run_v1.json","cohortCsvPath":"/repo/artifacts/downloads/training/pass101_patient_level_validation_cohort_template_v1.csv","sourceManifestJsonPath":null}